完全寛解期の限局性小細胞肺癌患者に対する放射線療法

基本情報

NCT ID: NCT00005062
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: -
治験依頼者名: Gustave Roussy, Cancer Campus, Grand Paris

概要

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and prevent the spread of cancer to the brain. It is not yet known if standard-dose radiation therapy is more effective than high-dose radiation therapy in preventing the spread of limited-stage small cell lung cancer cells to the brain. PURPOSE: This randomized phase III trial is comparing two different regimens of radiation therapy to see how well they work in treating patients with limited-stage small cell lung cancer in complete remission.

対象疾患

Lung Cancer

介入

radiation therapy(RADIATION)

依頼者（Sponsor）

European Organisation For Research And Treatment Of Cancer - Eortc(NETWORK)

Gustave Roussy, Cancer Campus, Grand Paris(OTHER)

実施施設 (1)

独立行政法人国立病院機構大阪医療センター

Osaka, Japan